
Meridian Bioscience VIVO
Quartalsbericht 2023-Q1
hinzugefügt 16.05.2026
Meridian Bioscience EV 2011-2026 | VIVO
EV Jährlich Meridian Bioscience
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.3 B | 833 M | 747 M | 488 M | 741 M | 586 M | 719 M | 719 M | 546 M | 864 M | 637 M | 568 M | -37.9 M | -54 M | -49.3 M | -49.4 M |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 1.3 B | -54 M | 535 M |
EV anderer Aktien in der Diagnostik & Forschung
| Name | EV | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
-19.1 M | - | -6.23 % | $ 30.6 M | ||
|
Heska Corporation
HSKA
|
851 M | - | - | $ 1.31 B | ||
|
Agilent Technologies
A
|
45.8 B | $ 115.9 | 0.73 % | $ 35.2 B | ||
|
Celcuity
CELC
|
5.57 B | $ 133.57 | -0.51 % | $ 6.25 B | ||
|
Akumin
AKU
|
1.64 B | - | -17.87 % | $ 25.9 M | ||
|
Co-Diagnostics
CODX
|
-1.92 M | $ 7.59 | -16.68 % | $ 10.1 M | ||
|
Castle Biosciences
CSTL
|
463 M | $ 20.94 | 6.35 % | $ 607 M | ||
|
Aspira Women's Health
AWH
|
10.6 M | - | -6.19 % | $ 10.5 M | ||
|
Accelerate Diagnostics
AXDX
|
69.5 M | - | -61.36 % | $ 2.46 M | ||
|
Biocept
BIOC
|
15 M | - | -13.05 % | $ 7.29 M | ||
|
Fulgent Genetics
FLGT
|
583 M | $ 17.68 | 0.03 % | $ 544 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
26.2 M | - | - | $ 562 M | ||
|
Guardant Health
GH
|
15.2 B | $ 125.25 | 4.51 % | $ 15.7 B | ||
|
CareDx, Inc
CDNA
|
1.04 B | $ 22.05 | 2.37 % | $ 1.17 B | ||
|
Chembio Diagnostics
CEMI
|
39.2 M | - | 0.22 % | $ 16.8 M | ||
|
Check-Cap Ltd.
CHEK
|
-2 K | - | - | $ 9.42 M | ||
|
HTG Molecular Diagnostics
HTGM
|
3.16 M | - | -20.0 % | $ 1.06 M | ||
|
Interpace Biosciences
IDXG
|
16.3 M | $ 1.8 | - | $ 7.96 M | ||
|
ICON Public Limited Company
ICLR
|
23.4 B | $ 117.6 | 3.29 % | $ 9.7 B | ||
|
Illumina
ILMN
|
15.3 B | $ 151.1 | 4.05 % | $ 24 B | ||
|
Global Cord Blood Corporation
CO
|
-2.71 B | - | - | $ 399 M | ||
|
Lantheus Holdings
LNTH
|
5.9 B | $ 99.53 | -0.53 % | $ 6.72 B | ||
|
Fluidigm Corporation
FLDM
|
6.64 M | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
3.34 M | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
251 M | - | 0.12 % | $ 80.1 M | ||
|
DermTech
DMTK
|
70.4 M | - | -11.32 % | $ 2.94 M | ||
|
Mettler-Toledo International
MTD
|
32.1 B | $ 1 093.48 | -0.71 % | $ 22.5 B | ||
|
Charles River Laboratories International
CRL
|
11.4 B | $ 163.66 | 4.54 % | $ 8.11 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
5.02 B | - | - | $ 10.7 B | ||
|
NeoGenomics
NEO
|
1.85 B | $ 9.52 | 2.7 % | $ 1.22 B | ||
|
Enzo Biochem
ENZ
|
-22.7 M | - | -8.98 % | $ 14.8 K | ||
|
Medpace Holdings
MEDP
|
14 B | $ 430.27 | 0.27 % | $ 12.4 B | ||
|
National Research Corporation
NRC
|
432 M | $ 19.04 | - | $ 426 M | ||
|
Natera
NTRA
|
5.53 B | $ 203.17 | 1.12 % | $ 20 B | ||
|
Exact Sciences Corporation
EXAS
|
22 B | - | - | $ 19.8 B | ||
|
Myriad Genetics
MYGN
|
598 M | $ 3.91 | 1.56 % | $ 362 M | ||
|
Personalis
PSNL
|
380 M | $ 9.35 | 4.53 % | $ 834 M | ||
|
Koninklijke Philips N.V.
PHG
|
43.5 B | $ 26.55 | -1.5 % | $ 25.2 B | ||
|
Senseonics Holdings
SENS
|
376 M | $ 6.27 | -2.49 % | $ 262 M | ||
|
QIAGEN N.V.
QGEN
|
11.3 B | - | - | $ 10.6 B | ||
|
Soleno Therapeutics
SLNO
|
2.13 B | - | - | $ 2.69 B | ||
|
Biomerica
BMRA
|
6.63 M | $ 2.38 | -3.64 % | $ 5.47 M | ||
|
Twist Bioscience Corporation
TWST
|
1.55 B | $ 64.96 | 0.14 % | $ 3.89 B | ||
|
Laboratory Corporation of America Holdings
LH
|
33.1 B | $ 259.0 | 0.23 % | $ 21.5 B | ||
|
Thermo Fisher Scientific
TMO
|
186 B | $ 452.36 | 0.92 % | $ 171 B | ||
|
Waters Corporation
WAT
|
21.6 B | $ 343.25 | 1.35 % | $ 20.4 B | ||
|
Trinity Biotech plc
TRIB
|
327 M | $ 0.67 | 3.54 % | $ 241 M | ||
|
Motus GI Holdings
MOTS
|
568 K | - | -34.28 % | $ 263 K | ||
|
Neogen Corporation
NEOG
|
2.26 B | $ 9.27 | 1.42 % | $ 2.01 B | ||
|
Quest Diagnostics Incorporated
DGX
|
22.9 B | $ 194.63 | 0.89 % | $ 21.6 B |